AstraZeneca confirms 1.55B voting rights outstanding
Rhea-AI Filing Summary
ASTRAZENECA PLC (AZN) reports its total voting rights as of 31 August 2026. The issued share capital with voting rights consists of 1,551,043,461 ordinary shares of US$0.25 each, and no shares are held in Treasury. Accordingly, the total number of voting rights is 1,551,043,461. Shareholders may use this figure as the denominator when calculating whether they must notify their interest, or any change in their interest, under the UK Financial Conduct Authority’s Disclosure and Transparency Rules.
Positive
- None.
Negative
- None.
Key Figures
Total voting rights: 1,551,043,461 voting rights
Issued share capital with voting rights: 1,551,043,461 ordinary shares
Nominal value per ordinary share: US$0.25 per ordinary share
+1 more
4 metrics
Total voting rights
1,551,043,461 voting rights
Total number of voting rights in AstraZeneca PLC as at 31 August 2026
Issued share capital with voting rights
1,551,043,461 ordinary shares
Issued ordinary shares of US$0.25 with voting rights as at 31 August 2026
Nominal value per ordinary share
US$0.25 per ordinary share
Nominal value of AstraZeneca PLC ordinary shares
Treasury shares
0 shares
Number of AstraZeneca PLC shares held in Treasury as at 31 August 2026
Key Terms
Total voting rights, issued share capital, Treasury, Disclosure and Transparency Rules, +1 more
5 terms
Total voting rights financial
"Therefore, the total number of voting rights in AstraZeneca PLC is 1,551,043,461."
The total voting rights number is the count of shares that carry the right to vote at a company’s shareholder meetings, reflecting how much voting power exists in the market. Investors use it to understand control and influence—like knowing how many votes are in play when measuring ownership stakes, calculating a shareholder’s voting percentage, or assessing how easy it would be for a holder to sway decisions.
Treasury financial
"No shares are held in Treasury."
The treasury is the department or area within a government or organization responsible for managing its money, finances, and financial strategies. It handles tasks like collecting revenue, paying bills, and planning for future financial needs, much like a household manages its budget. For investors, understanding the treasury is important because it influences interest rates, government spending, and overall economic stability.
Disclosure and Transparency Rules regulatory
"The following notification is made in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1."
Rules that require companies to provide accurate, timely and complete information about their finances, operations, risks and governance to regulators, investors and the public. They matter to investors because consistent, clear reporting is like a reliable scoreboard: it makes it easier to compare companies, spot problems early, reduce surprises and fraud, and form better expectations about future performance and value.
voting rights financial
"Therefore, the total number of voting rights in AstraZeneca PLC is 1,551,043,461."
Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.
FAQ
What is the total number of voting rights in AstraZeneca PLC (AZN) as of 31 August 2026?
As of 31 August 2026, AstraZeneca PLC has 1,551,043,461 total voting rights, corresponding to its issued share capital of ordinary shares with voting rights and no shares held in Treasury.
AI-generated analysis. How Rhea-AI works. Not financial advice.
